Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-02
1999-02-16
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514415, 514619, A61K 31445, A61K 31405, A61K 31165
Patent
active
058721339
ABSTRACT:
Methods for upregulating abnormal responses of the mammalian immune system are provided. Also disclosed are methods for modifying normal responses of the mammalian immune system. Further disclosed is a method for administering to a mammal a prolactin reducer and/or enhancer at a pre-determined time or times during a 24-hour period that results in modification of the mammal's abnormal prolactin profile so that it approaches or conforms to the prolactin profile of a young, healthy mammal of the same species (or to a standard profile generated from such individuals).
REFERENCES:
patent: 4310535 (1982-01-01), Pierpaoli
patent: 4665086 (1987-05-01), Short et al.
patent: 5028591 (1991-07-01), Edwards, III et al.
patent: 5145837 (1992-09-01), Feyen et al.
patent: 5344832 (1994-09-01), Cincotta et al.
patent: 5519047 (1996-05-01), Shelby et al.
Int. J. Immunology, vol. 13, Nos 2/3, Rovensky et al., "Evidence for Immunomodulatory Properties of Prolactin in Selected In Vitro and In Vivo Situtations", 1991 pp. 267-272.
Holaday, Neuroendocine -Immune Interactions and their Relevance to the Pharmacology of Critical Care Med., Klin Wochenschr (1991) 69 (Suppl. XXVI) :13-19.
Lopez -Karpovitch, Cellular and Humoral Immune Parameters in Women with Pathological Hyperprolactinemia Before and During treatment with BrC, AJrI, 1994: 31:32-39.
Berczi et al. Aeta Endocrinologica, 98:506-513 1980.
Berntun et al., Science, 239-401-4, 1989.
Reder et al. J. Neurological Sci, 117:192-196, 1992.
Gale, Proc. Soc. Exp. Biol. Med 198:513-27, 1991.
Nicoletti et al. J. Reprod. Immunol, 15:113-121, 1987.
McMurray et al. J. Immunol, 147: 3780-7, 1991.
Rovensky et al. Int. J Immunopharac. 13:267-272, 1991.
Vidaller et al. Clin. Immunol. Immunopathol, 38: 337-43, 1986.
Vidaller et al. J. Clin. Immunol, 12:210-215, 1992.
Rovensky et al., "Evidence . . . Situtions", Int. J. Immunopharmac., vol. 13, No. Feb. 3, pp. 267-272.
Lissoni et al., Eur F Cancer, 30:167-170, 1994.
Barnett et al., Postgraduate Medical Journal, 56:11-14, 1980.
Lissoni et al., Oncology, 51:344-347, 1994.
Meier et al., Experientia Birkunser Verlag., 48:248-253, 1992.
Lissoni, Oncology, 52:163-166, 1995.
Neri et al., Cancer, 73: 3015-3019, 1994.
Regelson et al., Cancer Investigation, 5:379-385, 1987.
Gutierez et al., Rev. Rhum. Ed. Fr., 61:278-85 1994.
Mattsson et al., Clin. Exp. Immunol., 85: 41-47, 1991.
Berczi, et al., Acta Endocrinologica, 98:506-513, 1980.
Berczi, Dev. Comp. Immunol., 13:329-341, 1989.
Bernton, E.S. et al., Science, 239:401-4, 1989.
Besedovsky, H. O. et al., J. Immunol., 135:750s-4s, 1985.
Blalock, J.E., Physiol. Rev., 69:1-32, 1989.
Blizhakov, J. Med., N.Y., 1980, 11 (2/3): 81-105.
Gala. R.R., Proc. Soc. Exp. Biol. Med. 198: 513-27, 1991.
Gutierrez, M.A., Rev. Rhum. Engl. Ed., 1994, 61/4, 261-267.
Hedner et al., Am. J. Ophthalmology, Oct. 1985, 618-619.
Holaday, J.W., "Neuroendocrine-Immune Interaction", 1991, 69 (Suppl. XXVI): 13-19.
Lopez-Korpovitch et al., AJRI, 1994, 31:32-39.
McMurray, R., et al., J. Immunol. 147:3780-7, 1991.
Parraquez et al., J. Dev. Physiol. (1991) 16(2): 57-62.
Nicoletti, I. et al., J. Reprod. Immunol., 15:113-121, 1989.
Reder, A.T. and Lowy, M.T., J. Neurological Sci., 117:192-196, 1992.
Reber, P.M., Am J. Med., 1993 95(6): 637-644.
Reichlin, S., NEJM 329: 1246-53, 1993.
Rovensky, J. et al., Int. J. Immunopharmac., 13:267-272, 1991.
Vidaller, A. et al., Clin. Immunol. Immunopathol. 38:337-43, 1986.
Vidaller, A. et al., J. Clin. Immunol., 12:210-5, 1992.
Dijkstra et al., Trends Pharmacol. Sci., 14:124-129, 1993.
Jara et al., Ame. J. of the Med. Sci., 303: 222-226, Apr. 1992.
Kukhtevich et al., The Genuine Article, abstract no. FX734, Terapevtichdkii Ardhiv, 63:99-101, 1991.
Folomeev et al., Biological Abstracts, vol. 90, Abstract no. 75731, Ter Arkh, 62:62-63, 1990.
Cincotta Anthony H.
Meier Albert H.
Geist Gary
Keys Rosalynd
The Board of Supervisors of Louisiana University and Agricultura
The General Hospital Corporation
LandOfFree
Method of regulating the immune response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of regulating the immune response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of regulating the immune response will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2062742